Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder

NeuroReport

Volumn 10, Issue 8, 1999, Pages 1747-1750

  Caberlotto, Laura ^a   Hurd, Yasmin L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Affective disorders; In situ hybridization; Major depression; Neuropeptide Y; Schizophrenia

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SUICIDE;

EID: 0033519574     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199906030-00022     Document Type: Article

References (25)

1. 1. Caberlotto L, Fuxe K, Overstreet DH et al. Mol Brain Res 59, 58-65 (1998).
2. 2. Malhé AA, Jimenez PA, Theodorsson E and Stenfors C. Prog Neuro-Psycopharmacol Biol Psychiat 22, 529-546 (1998).
3. 3. Widerlov E, Heilig M, Ekman R and Wahlestedt C. Nord Psykiatr Tidsskr 42, 131-137 (1988).
4. 4. Stenfors C, Theodorsson E and Mathé AA. J Neurosci Res 24, 445-450 (1989).
5. 5. Wahlestedt C, Blendy JA, Kellar KJ et al. Brain Res 507, 65-68 (1990).
6. 6. Weiner ED, Mallat A, Papolos DF and Lachman HM. Mol Brain Res 12, 203-214 (1992).
7. 7. Zachrisson O, Mathé AA, Stenfors C and Lindefors N. Neurosci Lett 194, 89-92 (1995).
8. 8. Widerlov E, Lodström LH, Wahlestedt C and Ekman R. J Psychiatr Res 22, 69-79 (1988).
9. 9. Hashimoto H, Onisne M, Koide S et al. Neurosci Lett 216, 57-60 (1996).
10. 10. Nilsson C, Karisson G, Blennow K et al. Peptides 17, 359-362 (1996).
11. 11. Widdowson PS, Ordway GA and Halaris AE. J Neurochem 59, 73-80 (1992).
12. 12. Mathé AA, Rudorfer MV, Stenfors C et al. Depression 3, 250-256 (1996).
13. 13. Berettini WH, Doran AR, Kalroe J et al. Neuropsychopharmacology 1, 81-83 (1987).
14. 14. Ordway GA, Stockineler CA, Meltzer HY et al. J Neurochem 65, 1646-1650 (1995).
15. 15. Irwin M, Brown M, Patterson T et al. FASEB J 5, 3100-3107 (1991).
16. 16. Frederiksen SO, Ekman R, Gottfries C-G et al. Acta Psychiatr Scand 83, 273-277 (1990).
17. 17 Caberlotto L, Fuxe K, Sedvall G and Hurd YL. Eur J Neurosci. 9, 1212-1225 (1997).
18. 18. Bren S, Lindefors N, Kopp J et al. Mol Brain Res 6, 241-249 (1989).
19. 19. Terenghi G, Polak JM, Hamid Q et al. Proc Natl Acad Sci USA 84, 7315-7318 (1987).
20. 20. Gjerris A, Widerlov, E, Werdelin L and Ekman R. J Psychiatr Neurosci 17, 23-27 (1992).
21. 21. Arraz B, Blennow K, Ekman R at al. Hum Psychopharmacol 11, 451-461 (1996).
22. 22. Bertolino A, Nawroz S, Mattay VS et al. Am J Psychiatr 153, 1554-1563 (1996).
23. 23. Dolan RJ, Bench CJ, Liddle PF et al. J Neurol Neurosurg Psychiatr 56, 1290-1294 (1993).
24. 24. Beal MF, Mazurek MF and Martin JB. Brain Res 405, 213-219 (1987).
25. 25. Beal MF, Mazurek MF, Lorenz LJ et al. Neurosci Lett 64, 69-74 (1986).